149 related articles for article (PubMed ID: 21818569)
1. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
[TBL] [Abstract][Full Text] [Related]
2. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
3. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
4. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D
J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598
[TBL] [Abstract][Full Text] [Related]
6. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling.
Minami K; Morita M; Saraya A; Yano H; Terauchi Y; Miki T; Kuriyama T; Kadowaki T; Seino S
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1289-96. PubMed ID: 12933351
[TBL] [Abstract][Full Text] [Related]
7. Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice.
Fagerholm V; Grönroos T; Marjamäki P; Viljanen T; Scheinin M; Haaparanta M
Eur J Pharmacol; 2004 Nov; 505(1-3):243-52. PubMed ID: 15556159
[TBL] [Abstract][Full Text] [Related]
8. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts.
Simões MV; Egert S; Ziegler S; Miyagawa M; Reder S; Lehner T; Nguyen N; Charron MJ; Schwaiger M
J Am Coll Cardiol; 2004 May; 43(9):1690-7. PubMed ID: 15120832
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
[TBL] [Abstract][Full Text] [Related]
10. An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse.
Kalliokoski T; Simell O; Haaparanta M; Viljanen T; Solin O; Knuuti J; Nuutila P
Diabetes Res Clin Pract; 2005 Dec; 70(3):217-24. PubMed ID: 15951047
[TBL] [Abstract][Full Text] [Related]
11. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
Santos SH; Fernandes LR; Mario EG; Ferreira AV; Pôrto LC; Alvarez-Leite JI; Botion LM; Bader M; Alenina N; Santos RA
Diabetes; 2008 Feb; 57(2):340-7. PubMed ID: 18025412
[TBL] [Abstract][Full Text] [Related]
12. Absence of insulin receptor substrate-1 expression does not alter GLUT1 or GLUT4 abundance or contraction-stimulated glucose uptake by mouse skeletal muscle.
Dumke CL; Wetter AC; Arias EB; Kahn CR; Cartee GD
Horm Metab Res; 2001 Dec; 33(12):696-700. PubMed ID: 11753753
[TBL] [Abstract][Full Text] [Related]
13. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing (18)F-FDG PET/CT.
Caobelli F; Pizzocaro C; Paghera B; Guerra UP
Nucl Med Commun; 2013 Mar; 34(3):271-5. PubMed ID: 23250295
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
Jackson RS; Schlarman TC; Hubble WL; Osman MM
J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
[TBL] [Abstract][Full Text] [Related]
15. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice.
Massollo M; Marini C; Brignone M; Emionite L; Salani B; Riondato M; Capitanio S; Fiz F; Democrito A; Amaro A; Morbelli S; Piana M; Maggi D; Cilli M; Pfeffer U; Sambuceti G
J Nucl Med; 2013 Feb; 54(2):259-66. PubMed ID: 23287574
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced DNA damage and the relative biological effectiveness of 18F-FDG in wild-type mice.
Taylor K; Lemon JA; Boreham DR
Mutagenesis; 2014 Jul; 29(4):279-87. PubMed ID: 24870562
[TBL] [Abstract][Full Text] [Related]
17. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice.
Lee KH; Ko BH; Paik JY; Jung KH; Choe YS; Choi Y; Kim BT
J Nucl Med; 2005 Sep; 46(9):1531-6. PubMed ID: 16157537
[TBL] [Abstract][Full Text] [Related]
18. Elevated 18F-FDG levels in blood and organs after angiotensin II receptor blocker administration: experiment in mice administered telmisartan.
Zhao Y; Zhao S; Kuge Y; Tamaki N
J Nucl Med; 2013 Aug; 54(8):1384-8. PubMed ID: 23833272
[TBL] [Abstract][Full Text] [Related]
19. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.
Wong KP; Sha W; Zhang X; Huang SC
J Nucl Med; 2011 May; 52(5):800-7. PubMed ID: 21498533
[TBL] [Abstract][Full Text] [Related]
20. Glucose uptake of the muscle and adipose tissues in diabetes and obesity disease models: evaluation of insulin and β3-adrenergic receptor agonist effects by
Ishino S; Sugita T; Kondo Y; Okai M; Tsuchimori K; Watanabe M; Mori I; Hosoya M; Horiguchi T; Kamiguchi H
Ann Nucl Med; 2017 Jun; 31(5):413-423. PubMed ID: 28401400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
